Assessment of global, segmental longitudinal deformation of the left ventricle and endothelial function in children with family hypercholesterolemia
https://doi.org/10.18705/2311-4495-2022-9-5-33-43
Abstract
Background. Familial hypercholesterolemia (FHC) is accompanied by a significant increase in the level of low-density lipoprotein cholesterol in the blood. The relevance of early diagnosis and treatment is due to the risk of premature development of atherosclerosis. Coronary heart disease due to atherosclerosis of the coronary arteries occurs among FHC patients up to 30 years. Currently, cardiac morphology and myocardial function in children with FHC are poorly understood. Objective. To assess global, segmental longitudinal deformation of the left ventricle and endothelial function in children with familial hypercholesterolemia. Design and methods. The study involved 25 healthy children and 34 children with FHC. Endothelin-1 and NO were determined by enzyme immunoassay. Echocardiographic study was carried. Assessment of global and segmental longitudinal deformation of the left ventricle was carried out in 4-chamber apical, 3-chamber and 2-chamber projections. Results. There were no statistically significant differences in global longitudinal strain (GLD) between groups. Individual analysis showed that 2 patients with FHC had a decrease in GLD. There was a statistically significant decrease in parameters in FHC patients at the level of the basal and apical anterior-septal, basal lower segments. Endothelin-1 and NO were increased in FHC compared to the control group. Conclusion. Speckle-tracking echocardiography allowed identifying patients with a decrease in global and segmental longitudinal deformation of the left ventricle among children with FHC.
Keywords
About the Authors
L. F. GalimovaRussian Federation
Liliya F. Galimova, PhD, doctor of ultrasound diagnostics, Children’s Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan, assistant of the Department of Hospital Pediatrics, Kazan State Medical University
Str. Orenburgskiy trakt, 140, Kazan, 420138
D. I. Sadykova
Russian Federation
Dinara I. Sadykova, MD, head of Department of Hospital Pediatrics
Kazan
T. P. Makarova
Russian Federation
Tamara P. Makarova, MD, Professor of the Department of Hospital Pediatrics
Kazan
A. A. Kamalova
Russian Federation
Aelita A. Kamalova, MD, professor of the Department of Hospital Pediatrics
Kazan
Yu. S. Melnikova
Russian Federation
Yulia S. Melnikova, PhD, assistant of the Department of Hospital Pediatrics
Kazan
E. S. Slastnikova
Russian Federation
Evgenia S. Slastnikova, PhD, assistant of the Department of Hospital Pediatrics
Kazan
R. F. Rakhmaeva
Russian Federation
Razilya F. Rakhmaeva, PhD, assistant of the Department of Hospital Pediatrics
Kazan
M. A. Petrova
Russian Federation
Maria A. Petrova, doctor, Children’s Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan, postgraduate student, Department of Hospital Pediatrics, Kazan State Medical University
Kazan
A. A. Mustafayeva
Russian Federation
Almira A. Mustafayeva, MD, deputy chief physician
Kazan
G. G. Semenova
Russian Federation
Gulnur G. Semenova, head of the Azino Polyclinic
Kazan
References
1. Clinical guidelines. Familial hypercholesterolemia. In Russian [Клинические рекомендации. Семейная гиперхолестеринемия.] https://noatero.ru/sites/default/files/proekt_ klinicheskie_rekomendacii_sghs_mz_rf_18.01.pdf (2018)
2.
3. Tokgozoglu L, Kayikcioglu M. Familial Hypercholesterolemia: Global Burden and Approaches. Curr Cardiol Rep. 2021; 23(10):151. DOI: 10.1007/s11886- 021-01565-5.
4.
5. Ershova AI, Meshkov AN, Bazhan SS, et al. The prevalence of familial hypercholesterolemia in the West Siberian region of the Russian Federation: A substudy of the ESSE-RF. PLoS One. 2017; 12(7):e0181148. DOI: 10.1371/ journal.pone.0181148.
6.
7. Karpov YuA, Kukharchuk VV, Boytsov SA, et al. Consensus statement of the Russian National Atherosclerosis Society (RNAS) familial hypercholesterolemia in Russia: outstanding issues in diagnosis and management. 2015; (2), 5–16. In Russian [Карпов Ю.А., Кухарчук В.В., Бойцов С.А. и др. Заключение совета экспертов Национального общества по изучению атеросклероза (НОА). Семейная гиперхолестеринемия в Российской Федерации: нерешенные проблемы диагностики и лечения. Атеросклероз и дислипидемии. 2015; (2), 5–16.]
8.
9. Borén J, Chapman MJ, Krauss RM, et al. Lowdensity lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2020; 41(24):2313–2330. DOI: 10.1093/eurheartj/ehz962.
10.
11. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/ EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020; 41(1):111–188. DOI: 10.1093/eurheartj/ehz455.
12.
13. Mabuchi H, Koizumi J, Shimizu M, et al. Development of coronary heart disease in familial hypercholesterolemia. Circulation. 1989; 79(2):225–232. DOI: 10.1161/01.cir.79.2.225.
14.
15. Mouratidis B, Vaughan-Neil EF, Gilday DL, et al. Detection of silent coronary artery disease in adolescents and young adults with familial hypercholesterolemia by single-photon emission computed tomography thallium-201 scanning. Am J Cardiol. 1992; 70(13):1109–1112. DOI: 10.1016/0002-9149(92)90038-z.
16.
17. Bruzzi P, Predieri B, Madeo S, et al. Longitudinal evaluation of endothelial markers in children and adolescents with familial hypercholesterolemia. Acta Biomed. 2021; 92(5):e2021343. DOI: 10.23750/abm.v92i5.11074.
18.
19. Kusters DM, Wiegman A, Kastelein JJ, et al. Carotid intima-media thickness in children with familial hypercholesterolemia. Circ Res. 2014; 114(2):307–310. DOI: 10.1161/CIRCRESAHA.114.301430.
20.
21. Atabaeva LS, Saidova MA, Shitov VN, et al. Myocardial deformation analysis combined with contrast stress-echocardiography — an additional method for assessment of myocardial ischemia. In Russian [Атабаева Л.С., Саидова М.А. Шитов В.Н. и др. Технология спекл-трекинг в сочетании с миокардиальной контрастной стресс-эхокардиографией — дополнительный способ оценки ишемии миокарда. Кардиологический вестник. 2021; 16(2): 43–52.] DOI: 10.17116/Cardiobulletin20211602143.
22.
23. Plana JC, Galderisi M, Barac A, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014; 27(9):911–939. DOI: 10.1016/j. echo.2014.07.012.
24.
25. Levy PT, Machefsky A, Sanchez AA, et al. Reference Ranges of Left Ventricular Strain Measures by Two-Dimensional Speckle-Tracking Echocardiography in Children: A Systematic Review and Meta-Analysis. J Am Soc Echocardiogr. 2016; 29(3):209–225.e6. DOI: 10.1016/j. echo.2015.11.016.
26.
27. Campbell MJ, Quartermain MD, Cohen MS, et al. Longitudinal changes in echocardiographic measures of ventricular function after Fontan operation. Echocardiography. 2020; 37(9):1443–1448. DOI: 10.1111/ echo.14826.
28.
29. Zoeller BB, Miyamoto SD, Younoszai AK, et al. Longitudinal Strain and Strain Rate Abnormalities Precede Invasive Diagnosis of Transplant Coronary Artery Vasculopathy in Pediatric Cardiac Transplant Patients. Pediatr Cardiol. 2016; 37(4):656–662. DOI: 10.1007/s00246- 015-1328-9.
30.
31. Popp TJ, Henshaw MH, Carter J, et al. Racial differences in myocardial deformation in obese children: Significance of inflammatory state. Nutr Metab Cardiovasc Dis. 2019; 29(4):378–382. DOI: 10.1016/j. numecd.2019.01.013.
32.
33. He M, Leone DM, Frye R, et al. Longitudinal Assessment of Global and Regional Left Ventricular Strain in Patients with Multisystem Inflammatory Syndrome in Children (MIS-C). Pediatr Cardiol. 2022;43(4):844–854. DOI: 10.1007/s00246-021-02796-7.
34.
35. Ahmed S, Strait K, RayChaudhuri N, et al. Global Longitudinal Strain Reduction in the Absence of Clinical Cardiac Symptoms in Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Case Series. Pediatr Cardiol. 2022; 43(1):233–237. DOI: 10.1007/ s00246-021-02712-z.
36.
37. Volgina SYa, Shurygin AD, Zaynutdinov AV, et al. Modern diagnostic criteria for Kawasaki disease in children. In Russian [Волгина С.Я., Шурыгин А.Д., Зайнутдинов А.В. и др. Современные диагностические критерии болезни кавасаки у детей. Российский педиатрический журнал. 2020; 23 (1): 48–56.] DOI: 10.18821/1560-9561- 2020-23-1-48-56.
38.
39. Neil HA, Hammond T, Huxley R, et al. Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study. BMJ. 2000; 321(7254):148. DOI: 10.1136/bmj.321.7254.148.
40.
41. Navarini S, Bellsham-Revell H, Chubb H, et al. Myocardial Deformation Measured by 3-Dimensional Speckle Tracking in Children and Adolescents With Systemic Arterial Hypertension. Hypertension. 2017; 70(6):1142–1147. DOI: 10.1161/HYPERTENSIONAHA.
42.
43. Zhang C, Deng Y, Liu Y, et al. Preclinical cardiovascular changes in children with obesity: A real-time 3-dimensional speckle tracking imaging study. PLoS One. 2018; 13(10):e0205177. DOI: 10.1371/journal.pone.0205177.
44.
45. Vitarelli A, Martino F, Capotosto L, et al. Early myocardial deformation changes in hypercholesterolemic and obese children and adolescents: a 2D and 3D speckle tracking echocardiography study. Medicine (Baltimore). 2014; 93(12):e71. DOI: 10.1097/MD.0000000000000071.
46.
47. Lee TM, Chou TF, Tsai CH. Association of pravastatin and left ventricular mass in hypercholesterolemic patients: role of 8-iso-prostaglandin f2alpha formation. J Cardiovasc Pharmacol. 2002; 40(6):868–874. DOI: 10.1097/00005344-200212000-00007.
48.
49. Rajapurohitam V, Javadov S, Purdham DM, et al. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1. J Mol Cell Cardiol. 2006; 41(2):265–274. DOI: 10.1016/j. yjmcc.2006.05.001.
50.
51. Chadjichristos CE, Matter CM, Roth I, et al. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice. Circulation. 2006; 113(24):2835–2843. DOI: 10.1161/ CIRCULATIONAHA.106.627703.
Review
For citations:
Galimova L.F., Sadykova D.I., Makarova T.P., Kamalova A.A., Melnikova Yu.S., Slastnikova E.S., Rakhmaeva R.F., Petrova M.A., Mustafayeva A.A., Semenova G.G. Assessment of global, segmental longitudinal deformation of the left ventricle and endothelial function in children with family hypercholesterolemia. Translational Medicine. 2022;9(5):33-43. (In Russ.) https://doi.org/10.18705/2311-4495-2022-9-5-33-43